Clinical considerations for critically ill COVID-19 cancer patients: A systematic review

doi:10.12998/wjcc.v9.i28.8441

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4813)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

401

WORD

157

HTML

2610

Figures (1-4)

199

Tables (1-1)

192

Sum=3559

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

439

Download

815

Sum=1254

Oct 6, 2021 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Cases. Oct 6, 2021; 9(28): 8441-8452
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8441

Full Size Figure Download Figure

Figure 4 Contributors of worse outcome of among cancer patients with coronavirus disease 2019 infection. ¹Higher levels of C-reactive protein, D-dimer, ferritin and procalcitonin.

Citation: Ramasamy C, Mishra AK, John KJ, Lal A. Clinical considerations for critically ill COVID-19 cancer patients: A systematic review. World J Clin Cases 2021; 9(28): 8441-8452
URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8441.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8441